COVID-19 Booster May Spur Seroconversion in Blood Cancer Patients
Among nonresponders to initial COVID-19 vaccination, seroconversion occurred in 56 percent following booster dose.
Diagnosis & Disease Information
Third Dose of COVID-19 Vaccine Appears Least Effective for Lymphoma Patients
Vaccine effectiveness against breakthrough SARS-CoV-2 infections was 10.5% for patients with lymphoma.
Low Adoption of SC-RT for Lymphoma Among Medicare Beneficiaries
Researchers sought to determine the trends in the utilization of Medicare on short-course radiotherapy in patients with lymphoma.
Worldwide Drop in Cancer Screening Seen Early in Pandemic
Significant drops in cancer screening observed for several types of cancer.
Lack of Mask Mandates Leaves Cancer Patients Feeling Unprotected
Cancer patients have voiced concerns about a lack of masking at cancer centers and have reported being harassed for wearing masks in public.
No Increased Risk of irAEs Seen After COVID-19 Vaccination in Patients on ICIs
Patients with lung cancer who underwent COVID-19 vaccination while receiving immune checkpoint inhibitors did not have an increased risk of immune-related adverse events.
Disruption to Oncology Clinical Trials Seen Early in Pandemic
Numbers of new patient accruals and newly activated trials decreased early on, followed by progressive recovery.
Screening Mammography Levels Not Fully Restored After Pandemic Drop
While mammography, biopsies, and cancer diagnoses are up from 2020 lows, none have reached pre-COVID-19 volumes.
Evusheld Appears Less Effective Against Omicron for Patients With Blood Cancer
A single 150 mg dose of Evusheld demonstrated neutralizing activity against wild-type SARS-CoV-2 but not the omicron variant.
Lymphoma Treatment Associated With Impaired Response to COVID-19 Vaccination
Researchers sought to determine whether patients with lymphoma receiving anticancer therapy had responses to COVID-19 vaccination.
- Loading...
Loading...
Loading... 
Loading...